Acumen Pharmaceuticals Ownership | Who Owns Acumen Pharmaceuticals?
Acumen Pharmaceuticals Ownership Summary
Acumen Pharmaceuticals is owned by 72.58% institutional investors, 11.24% insiders, and 16.19% retail investors. Ra capital management is the largest institutional shareholder, holding 24.96% of ABOS shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 2.46% of its assets in Acumen Pharmaceuticals shares.
ABOS Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Acumen Pharmaceuticals | 72.58% | 11.24% | 16.19% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Ra capital management | 14.93M | 24.96% | $36.14M |
Sands capital ventures | 3.42M | 5.71% | $8.27M |
Franklin resources | 3.37M | 5.63% | $8.15M |
Rock springs capital management lp | 2.30M | 3.85% | $5.57M |
Blackrock | 2.16M | 3.61% | $5.22M |
Fmr | 2.02M | 3.38% | $4.89M |
Millennium management | 1.95M | 3.27% | $4.73M |
Vanguard group | 1.90M | 3.17% | $4.59M |
Knollwood investment advisory | 1.63M | 2.72% | $3.94M |
Laurion capital management lp | 1.18M | 1.97% | $2.85M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Sands capital ventures | 3.42M | 2.77% | $8.27M |
Ra capital management | 14.93M | 0.48% | $36.14M |
Knollwood investment advisory | 1.63M | 0.44% | $3.94M |
Rock springs capital management lp | 2.30M | 0.17% | $5.57M |
Ikarian capital | 266.44K | 0.11% | $644.77K |
Catalyst financial partners | 89.70K | 0.05% | $217.07K |
Laurion capital management lp | 1.18M | 0.03% | $2.85M |
Intrepid financial planning group | 30.15K | 0.03% | $72.96K |
Alyeska investment group | 939.60K | 0.01% | $2.27M |
Bridgeway capital management | 148.40K | 0.01% | $359.13K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 2.16M | 0.00% | 1.97M |
Geode capital management | 812.13K | 0.00% | 526.99K |
State street | 436.56K | - | 354.79K |
Renaissance | 338.10K | 0.00% | 338.10K |
Vanguard group | 1.90M | 0.00% | 231.89K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Laurion capital management lp | 1.18M | 0.03% | -716.68K |
Millennium management | 1.95M | 0.00% | -675.46K |
Parkman healthcare partners | - | - | -576.66K |
Goldman sachs group | 51.05K | - | -266.85K |
Tang capital management | - | - | -246.90K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Renaissance | 338.10K | 0.00% | 338.10K | $818.20K |
Bank of new york mellon | 126.42K | 0.00% | 126.42K | $305.94K |
Charles schwab investment management | 108.74K | 0.00% | 108.74K | $263.16K |
Nuveen asset management | 56.66K | - | 56.66K | $137.13K |
Rhumbline advisers | 52.32K | 0.00% | 52.32K | $126.62K |
Sold Out
Holder | Change |
---|---|
Redwood wealth management group | -800.00 |
Kelly financial services | -944.00 |
Macquarie group | -1.25K |
Sandy spring bank | -1.50K |
Point72 (difc) | -4.02K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 77 | -10.47% | 43,605,266 | 0.06% | 72 | 1.37% | 34 | -24.44% | 21 | 10.53% |
Jun 30, 2024 | 86 | 2.38% | 43,581,297 | 0.50% | 72 | 1.30% | 45 | -8.16% | 19 | -13.64% |
Mar 31, 2024 | 84 | 16.67% | 43,366,076 | 12.88% | 74 | 1.49% | 49 | 4.26% | 22 | 144.44% |
Dec 31, 2023 | 72 | -1.37% | 38,419,207 | -11.04% | 70 | 0.64% | 47 | - | 9 | -18.18% |
Sep 30, 2023 | 73 | 21.67% | 43,186,726 | 63.99% | 105 | 2.55% | 47 | 104.35% | 11 | -45.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Franklin Biotechnology Discv A(acc)USD | 1.48M | 2.46% | - |
Franklin Small Cap Growth SMA | 1.19M | 1.98% | 1.19M |
Franklin US Small Cap Growth Equity | 1.19M | 1.98% | -12.21K |
Franklin Small Cap Growth Adv | 1.19M | 1.98% | - |
Vanguard Total Stock Mkt Idx Inv | 1.15M | 1.91% | - |
Fidelity Select Health Care | 1.14M | 1.90% | - |
iShares Russell 2000 ETF | 1.01M | 1.68% | -2.27K |
Franklin Biotechnology Discovery A | 826.40K | 1.38% | - |
Fidelity Advisor Health Care I | 700.00K | 1.17% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 472.17K | 0.79% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jan 19, 2024 | OConnell Daniel Joseph | President and CEO | Sell | $52.75K |
Jan 19, 2024 | Meisner Derek M | Chief Legal Officer & Corp Sec | Sell | $31.05K |
Jan 18, 2024 | Zuga Matt | CFO & Chief Business Officer | Sell | $15.72K |
Jan 18, 2024 | Siemers Eric | Chief Medical Officer | Sell | $11.60K |
Jan 18, 2024 | Barton Russell | Chief Operating Officer | Sell | $10.56K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | - |
2024 Q2 | - | - |
2024 Q1 | - | 5 |
2023 Q3 | 1 | 2 |
2023 Q2 | - | - |
ABOS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools